SCHEMBL23596132

SCHEMBL23596132

c1ccc(-c2cccc(-c3oc(-c4ccccc4)c4ccccc34)c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.42
PLA2G4A P47712 3/20 0.42
MAOA P21397 1/20 0.41
KMO O15229 1/20 0.41
PSMB8 P28062 1/20 0.41
IP6K1 Q92551 1/20 0.41
IP6K3 Q96PC2 1/20 0.41
IP6K2 Q9UHH9 1/20 0.41
ALDH1A1 P00352 2/20 0.39
PLA2G10 O15496 1/20 0.39
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ESR1 P03372 1/20 0.38
KDM4E B2RXH2 2/20 0.38
CYP3A4 P08684 2/20 0.38
DDR2 Q16832 1/20 0.38
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23596640 0.87 PRKDC (0.38) PLA2G2APLA2G4AMAOAKMOPSMB8
SCHEMBL23596264 0.86 ALDH1A1 (0.47) PLA2G2APLA2G4AALDH1A1MEN1KMT2A
SCHEMBL297968 0.86 KDM4E (0.45) ALDH1A1MEN1KMT2AKDM4ECYP3A4
SCHEMBL27936018 0.86 KDM4E (0.45) ALDH1A1MEN1KMT2AKDM4ECYP3A4
SCHEMBL23596645 0.85 PRKDC (0.37) PLA2G2APLA2G4AMAOAKMOPSMB8
SCHEMBL23597347 0.85 MAOA (0.38) PLA2G2APLA2G4AMAOAKMOPSMB8
SCHEMBL23596292 0.84 PRKDC (0.36) PLA2G2APLA2G4AMAOAKMOPSMB8
SCHEMBL23597047 0.84 PLA2G2A (0.36) PLA2G2APLA2G4AMAOAKMOPSMB8
SCHEMBL23596641 0.84 MEN1 (0.40) PLA2G2APLA2G4AMAOAKMOPSMB8
SCHEMBL23596642 0.84 MEN1 (0.40) PLA2G2APLA2G4AMAOAKMOPSMB8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691957-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-04 US disclosed
US-11691957-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-07-04 US disclosed
US-20210198222-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210198222-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CCNT1, CCNA1 PLA2G2A 2436/4885PLA2G4A 2874/4885MAOA 2992/4885
US-11691957-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CCNT1, CCNA1 PLA2G2A 2436/4885PLA2G4A 2874/4885MAOA 2992/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.